NEO-CYT positions MDNA11 in a frontline neoadjuvant melanoma setting, where immunotherapy before surgery may help generate deeper and more durable anti-tumor immune responses ...
Seadrill Limited (NYSE: SDRL) ("Seadrill" or the "Company") today announced the 2026 Annual General Meeting of the Shareholders of the Company was held on June 3, 2026, at the Hamilton Princess Hotel ...